Julien Miara has more than 10 years of experience in finance and biotechnology. He is a Director at Invus where he joined in 2010 as an analyst in the Public Equity group, covering Biotechnology among other sectors. In September 2020, the Board of Directors of Onxeo co-opted Julien Miara, representing Invus Public Equities LP, as a director of the Company. His cooptation as a director was ratified in June 2021. Miara worked in investment banking at BNP Paribas in Paris and Société Générale in New-York, as well as in management consulting. He received his Master of Management from EDHEC Business School in Lille (France) in 2009. The recruitment process for a new CEO is ongoing.